Related Experiment Video
Updated: May 11, 2026

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
Published on: June 6, 2025
Cardiac failure, transplantation and donation: current perspectives.
1Department of Cardiothoracic Surgery, The Prince Charles Hospital, Chermside, Queensland, Australia - hasanatsharif2@yahoo.com.
Current heart failure treatments, including stem cell grafting and ventricular assist devices, show promise but often act as bridges to cardiac transplantation. Challenges in transplantation, especially in developing nations, limit its use and highlight the need to improve donor-recipient ratios.
Area of Science:
- Cardiology
- Regenerative Medicine
- Transplantation Medicine
Background:
- Cardiac failure is a major global health issue with significant morbidity and mortality.
- Existing treatments for end-stage heart failure vary in safety and efficacy.
- Novel therapies like stem cell grafting and left ventricular assist devices (LVADs) are emerging.
Purpose of the Study:
- To review current perspectives on heart failure treatment modalities.
- To highlight advancements in stem cell therapy and LVADs as bridges to transplantation.
- To examine challenges in cardiac transplantation, particularly in developing countries, and explore solutions to improve the donor-recipient ratio.
Main Methods:
- Comprehensive literature review of recent years.
- Analysis of current advancements, knowledge, and research trends in heart failure management.
- Exploration of factors limiting modern treatment adoption in developing nations.
Main Results:
- Stem cell grafting and LVADs offer promising transient and permanent therapeutic options for end-stage heart failure.
- Cardiac transplantation remains the definitive treatment but faces significant global limitations.
- Barriers to cardiac donation and transplantation in developing countries require targeted interventions.
Conclusions:
- While novel therapies advance, cardiac transplantation faces challenges hindering widespread application.
- Addressing the low donor-recipient ratio is critical for improving heart failure management globally.
- Further research and policy changes are needed to enhance access to advanced heart failure treatments, especially in resource-limited settings.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care
Kidney Transplant II: Surgical Procedure
Cardiomyopathy II: Dilated Cardiomyopathy
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

